Cerep

Cerep is a leading brand in the field of molecular biology and genetic testing, offering a wide range of products and services. Established in 1989, Cerep has become a trusted name in the industry, providing innovative solutions for scientific research and clinical diagnostics. With its headquarters located in Celle L'Evescault, France, Cerep operates under Eurofins France, a renowned global player in the life sciences sector.

Cerep's offerings include comprehensive information and financial services, as well as regulatory compliance solutions. Whether it's information on financial performance, regulatory requirements, or documents and reports, Cerep ensures transparency and accessibility for its investors. Under the governance of a dedicated board of directors, led by President Damien Séroux and Director General Administrator Antoine Duthilleul, Cerep maintains a strong commitment to corporate governance.

Its shares are listed on Euronext Paris and Euronext Growth, reflecting Cerep's solid market presence and successful track record. For investors and stakeholders seeking reliable information and continuous updates, Cerep's investor relations team can be reached through their dedicated email address: fincom. cerep-sa@eurofins.

com. Trust Cerep's expertise and experience in the field and explore the vast array of services they offer to advance scientific discovery and healthcare outcomes worldwide